Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Minimal Residual Disease in Multiple Myeloma in Serum by Mass Spectrometry

NCT07691034 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT07691034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07691034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Minimal Residual Disease in Multiple Myeloma in Serum by Mass Spectrometry
Lead sponsor
Odense University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
August 4, 2026
Completion date
June 30, 2035
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

minimal residual disease, multiple myeloma